Target intelligence / Profile preview

Non-metastatic cells 2, protein expressed (pseudogene) (Null)

Target
Null
Molecular classification
Other (Pseudogene)
01

Overview

This gene (ENSG00000233933) corresponds to a pseudogene related to the non-metastatic cells 2, protein (a nucleoside diphosphate kinase) family. Pseudogenes are genetically similar to protein-coding genes but are rendered nonfunctional by disabling mutations and are not translated into proteins[3][4]. Recent research shows some pseudogenes are transcribed and can regulate other genes via RNA-based mechanisms, but the vast majority—including this one—have no well-defined biological or therapeutic role and are not regarded as valid drug targets. The use of "protein expressed in pseudogene" is non-standard; typically, the parent gene should be specified for clarity[1][4]. Key Context: - Pseudogenes are "molecular corpses"—segments of DNA resembling protein-coding genes but lacking coding potential due to disabling mutations[3]. - Rarely, some pseudogenes are transcribed and give rise to regulatory non-coding RNAs, but these are exceptions[1][4]. - Although studied for potential regulatory or biomarker roles, especially in cancer, ENSEMBL gene ENSG00000233933 and its described function as "non-metastatic cells 2, protein expressed in pseudogene" do not meet criteria as a drug target, receptor, or biomarker in clinical or research use[1][4]. Note: If you need structured information about active protein-coding targets, a different gene or protein should be specified. This entry is likely incorrect for therapeutic targeting purposes.

Other names
Non-metastatic cells 2, protein expressed, pseudogeneNME2P
02

Mechanism of action

Null

03

Biological functions

Other (Non-coding RNA regulation, if any function at all)
04

Disease associations

Other (No established role; pseudogenes sometimes involved in post-transcriptional regulation or disease-relevant pathways only in rare, well-studied cases[1][4])

Beyond the preview

Go deeper on Non-metastatic cells 2, protein expressed (pseudogene) (Null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-metastatic cells 2, protein expressed (pseudogene) (Null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call